<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; metastatic</title>
	<atom:link href="http://www.tapanray.in/tag/metastatic/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>How Cost-Effective Are New Cancer Drugs?</title>
		<link>http://www.tapanray.in/how-cost-effective-are-new-cancer-drugs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=how-cost-effective-are-new-cancer-drugs</link>
		<comments>http://www.tapanray.in/how-cost-effective-are-new-cancer-drugs/#comments</comments>
		<pubDate>Mon, 30 Jan 2017 00:00:05 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[anticancer]]></category>
		<category><![CDATA[assessment]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Buffet]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[effective]]></category>
		<category><![CDATA[effectiveness]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[JAMA]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[malignant]]></category>
		<category><![CDATA[metastatic]]></category>
		<category><![CDATA[Natco]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Nexavar]]></category>
		<category><![CDATA[oncology]]></category>
		<category><![CDATA[prices]]></category>
		<category><![CDATA[prolong]]></category>
		<category><![CDATA[rate]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[survival]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[Warren]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8061</guid>
		<description><![CDATA[The main reason why cancer is so serious a disease, is the ability of the malignant cells to spread in the body, both locally by moving into nearby normal tissue, and regionally to nearby lymph nodes, tissues, or organs, affecting even &#8230; <a href="http://www.tapanray.in/how-cost-effective-are-new-cancer-drugs/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/how-cost-effective-are-new-cancer-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
